Contacts

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

CONTACT

1-317-615-4559 LillyTrials@Lilly.com

Physicians interested in becoming principal investigators please contact

CONTACT

clinical_inquiry_hub@lilly.com

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Meet the diagnostic criteria for major depressive disorder
•Are on a stable standard of care medication for major depressive disorder
•Are reliable and willing to make themselves available for the duration of the study and attend required study visits, and are willing and able to follow study procedures as required, such as
•* self-inject study intervention
•* store and use the provided blinded study intervention, as directed
•* maintain electronic and paper study diaries, as applicable, and
•* complete the required questionnaires

Exclusion Criteria

•Have a lifetime history or current diagnosis of the following:
•* schizophrenia or other psychotic disorder
•* bipolar disorder
•* borderline personality disorder, or
•* any eating disorder.
•Have type 1 diabetes mellitus, or a history of
•* ketoacidosis, or
•* hyperosmolar state or coma.
•Evidence of moderate or severe substance or alcohol use disorder within 180 days of screening
•Are actively suicidal or deemed a significant risk for suicide
•Have participated in a clinical study and received active treatment, or unknown if they received active treatment, within 90 days or 5 half-lives (whichever is longer) before screening

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

NCT07227454 · Depressive Disorder, Major

RECRUITINGPhase 3

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

NCT06860958 · Depressive Disorder, Major

RECRUITINGPhase 3

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

NCT05415397 · Depressive Disorder, Major, Inflammation

RECRUITINGNA

The Motor Activity - Subjective Energy (MASE) Project

NCT07059234 · Depressive Disorder, Major

RECRUITING

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

NCT06396312 · Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms, Depressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms), and more

View all related studies →

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

What this study is about

Save this trial guide to your notes

Contacts

Sponsors

Related studies

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

The Motor Activity - Subjective Energy (MASE) Project

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Trial snapshot

Condition

Locations shown

For caregivers